Free Trial

What is Zacks Research's Forecast for Delek US Q2 Earnings?

Delek US logo with Energy background

Key Points

  • Analysts at Zacks Research have raised their Q2 2026 earnings per share (EPS) estimate for Delek US to $0.27, up from $0.23, despite a current full-year earnings consensus estimate of ($5.50) per share.
  • Delek US reported a quarterly EPS of (0.56), beating estimates by $0.36, but saw revenue decline by 16.4% compared to the previous year.
  • Institutional investors own approximately 97.01% of Delek US, with significant recent investments including AlphaQuest LLC increasing their stake by 7,331.8%.
  • Five stocks to consider instead of Delek US.

Delek US Holdings, Inc. (NYSE:DK - Free Report) - Analysts at Zacks Research lifted their Q2 2026 earnings per share (EPS) estimates for Delek US in a note issued to investors on Thursday, September 25th. Zacks Research analyst Team now expects that the oil and gas company will earn $0.27 per share for the quarter, up from their previous estimate of $0.23. The consensus estimate for Delek US's current full-year earnings is ($5.50) per share.

Delek US (NYSE:DK - Get Free Report) last released its quarterly earnings results on Wednesday, August 6th. The oil and gas company reported ($0.56) EPS for the quarter, beating analysts' consensus estimates of ($0.92) by $0.36. Delek US had a negative net margin of 7.11% and a negative return on equity of 79.27%. The firm had revenue of $2.76 billion for the quarter, compared to analyst estimates of $2.68 billion. During the same period in the previous year, the business earned ($0.92) earnings per share. The company's revenue for the quarter was down 16.4% compared to the same quarter last year.

Other analysts have also recently issued reports about the company. Bank of America raised their price objective on Delek US from $14.00 to $24.00 and gave the company an "underperform" rating in a research report on Wednesday, September 3rd. Scotiabank reiterated a "sector perform" rating and issued a $20.00 price objective (up previously from $14.00) on shares of Delek US in a report on Friday, July 11th. The Goldman Sachs Group increased their price objective on shares of Delek US from $25.00 to $28.00 and gave the stock a "neutral" rating in a research report on Monday, September 15th. Wells Fargo & Company upped their price objective on shares of Delek US from $11.00 to $15.00 and gave the company an "underweight" rating in a report on Wednesday, June 11th. Finally, Raymond James Financial boosted their price objective on Delek US from $26.00 to $33.00 and gave the stock an "outperform" rating in a report on Tuesday, September 9th. Three equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and three have given a Sell rating to the company. According to data from MarketBeat.com, the company presently has an average rating of "Hold" and an average price target of $26.54.

Check Out Our Latest Research Report on Delek US

Delek US Trading Up 2.6%

NYSE:DK opened at $33.58 on Friday. The business's 50-day simple moving average is $26.12 and its 200-day simple moving average is $20.57. The stock has a market capitalization of $2.02 billion, a PE ratio of -2.73 and a beta of 1.09. The company has a debt-to-equity ratio of 10.48, a current ratio of 0.80 and a quick ratio of 0.50. Delek US has a fifty-two week low of $11.02 and a fifty-two week high of $34.50.

Delek US Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, August 18th. Investors of record on Monday, August 11th were given a dividend of $0.255 per share. This represents a $1.02 annualized dividend and a yield of 3.0%. The ex-dividend date was Monday, August 11th. Delek US's payout ratio is -8.30%.

Insider Activity at Delek US

In other news, CFO Robert G. Wright sold 7,135 shares of the business's stock in a transaction dated Tuesday, September 2nd. The stock was sold at an average price of $29.24, for a total value of $208,627.40. Following the transaction, the chief financial officer directly owned 48,294 shares in the company, valued at $1,412,116.56. The trade was a 12.87% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 1.80% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of DK. AlphaQuest LLC lifted its position in shares of Delek US by 7,331.8% during the second quarter. AlphaQuest LLC now owns 1,635 shares of the oil and gas company's stock valued at $35,000 after buying an additional 1,613 shares during the last quarter. CWM LLC lifted its holdings in Delek US by 100.9% during the first quarter. CWM LLC now owns 2,318 shares of the oil and gas company's stock valued at $35,000 after purchasing an additional 1,164 shares in the last quarter. Creative Financial Designs Inc. ADV acquired a new position in Delek US in the 1st quarter valued at $47,000. GAMMA Investing LLC lifted its stake in shares of Delek US by 907.0% in the first quarter. GAMMA Investing LLC now owns 4,159 shares of the oil and gas company's stock worth $63,000 after buying an additional 3,746 shares in the last quarter. Finally, State of Wyoming acquired a new position in Delek US during the first quarter worth $95,000. Hedge funds and other institutional investors own 97.01% of the company's stock.

Delek US Company Profile

(Get Free Report)

Delek US Holdings, Inc engages in the integrated downstream energy business in the United States. The company operates through Refining, Logistics, and Retail segments. The Refining segment processes crude oil and other feedstock for the manufacture of various grades of gasoline, diesel fuel, aviation fuel, asphalt, and other petroleum-based products that are distributed through owned and third-party product terminal.

Featured Articles

Earnings History and Estimates for Delek US (NYSE:DK)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Delek US Right Now?

Before you consider Delek US, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Delek US wasn't on the list.

While Delek US currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for October 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.